ATA357579A - Verfahren zur gewinnung einer transfer ribonecleinsaeure mit antiviraler wirkung - Google Patents

Verfahren zur gewinnung einer transfer ribonecleinsaeure mit antiviraler wirkung

Info

Publication number
ATA357579A
ATA357579A AT793575A AT357579A ATA357579A AT A357579 A ATA357579 A AT A357579A AT 793575 A AT793575 A AT 793575A AT 357579 A AT357579 A AT 357579A AT A357579 A ATA357579 A AT A357579A
Authority
AT
Austria
Prior art keywords
ribonecleic
obtaining
transfer
acid
antiviral effect
Prior art date
Application number
AT793575A
Other languages
English (en)
Other versions
AT367770B (de
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ATA357579A publication Critical patent/ATA357579A/de
Application granted granted Critical
Publication of AT367770B publication Critical patent/AT367770B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT0357579A 1978-06-03 1979-05-15 Verfahren zur gewinnung einer transfer -ribonucleinsaeure mit antiviraler wirkung AT367770B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782824411 DE2824411A1 (de) 1978-06-03 1978-06-03 Antiviral wirksame t-rna-praeparate

Publications (2)

Publication Number Publication Date
ATA357579A true ATA357579A (de) 1981-12-15
AT367770B AT367770B (de) 1982-07-26

Family

ID=6040941

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0357579A AT367770B (de) 1978-06-03 1979-05-15 Verfahren zur gewinnung einer transfer -ribonucleinsaeure mit antiviraler wirkung

Country Status (16)

Country Link
US (1) US4213970A (de)
JP (1) JPS54160746A (de)
AT (1) AT367770B (de)
AU (1) AU526125B2 (de)
BE (1) BE876739A (de)
DE (1) DE2824411A1 (de)
DK (1) DK230679A (de)
ES (1) ES481225A1 (de)
FI (1) FI791774A (de)
FR (1) FR2427098A1 (de)
GB (1) GB2022412B (de)
IE (1) IE48155B1 (de)
IT (1) IT1117170B (de)
LU (1) LU81348A1 (de)
NL (1) NL7904340A (de)
SE (1) SE7904840L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
LT4475B (lt) * 1997-02-28 1999-02-25 Virmantas Stunžėnas Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
AU2023400A (en) * 1998-11-12 2000-05-29 Children's Medical Center Corporation Compositions and methods for inhibiting angiogenesis using trna and fragments thereof
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4269M (de) * 1964-12-09 1966-07-11
US3389133A (en) * 1966-08-10 1968-06-18 Schwarz Biores Inc Process for isolating and purifying soluble ribonucleic acid
BE757291A (fr) * 1969-10-10 1971-04-09 Smith Kline French Lab Complexe antiviral de arn et d'un polysaccharide
BE757653A (fr) * 1969-10-21 1971-04-16 Ugine Kuhlmann Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
GB1300567A (en) * 1969-12-20 1972-12-20 Beecham Group Ltd Therapeutic compositions
DE2034118A1 (en) * 1970-07-09 1972-01-13 Seinfeld, Hugo, Brendel, Walter, Prof Dr . 8000 München Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
US4124702A (en) * 1971-07-06 1978-11-07 Merck & Co., Inc. Polynucleotides active as inducers of interferon production in living animal cells
US3966707A (en) * 1971-11-26 1976-06-29 Beecham Group Limited Process for preparing double stranded RNA

Also Published As

Publication number Publication date
US4213970A (en) 1980-07-22
GB2022412A (en) 1979-12-19
IT1117170B (it) 1986-02-17
IE791084L (en) 1979-11-12
FR2427098A1 (fr) 1979-12-28
AU4769679A (en) 1979-12-13
DE2824411A1 (de) 1979-12-13
DK230679A (da) 1979-12-04
JPS54160746A (en) 1979-12-19
AU526125B2 (en) 1982-12-16
NL7904340A (nl) 1979-12-05
LU81348A1 (de) 1980-12-16
FI791774A (fi) 1979-12-04
SE7904840L (sv) 1979-12-04
ES481225A1 (es) 1980-08-16
GB2022412B (en) 1982-12-22
BE876739A (fr) 1979-12-03
FR2427098B1 (de) 1984-02-24
IE48155B1 (en) 1984-10-17
IT7949268A0 (it) 1979-06-01
AT367770B (de) 1982-07-26

Similar Documents

Publication Publication Date Title
DD135768A5 (de) Verfahren zur herstellung von guajaconsaeure a
AT375817B (de) Verfahren zur herstllung einer speiseeiszubereitung
AT358015B (de) Verfahren zur herstellung einer 2-arylpropion- saeure
AT371715B (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
AT374773B (de) Verfahren zur herstellung einer gereinigten ammoniummolybdatloesung
AT363177B (de) Verfahren zur herstellung einer stabilen thymosinfraktion 5
ATA151278A (de) Verfahren zur herstellung einer tontaube
ATA357579A (de) Verfahren zur gewinnung einer transfer ribonecleinsaeure mit antiviraler wirkung
ATA537879A (de) Verfahren zur herstellung von 0-(2,6dichloranilino)-phenylessigsaeure oder einer salzes oder curboxylgruppe
AT375876B (de) Verfahren zur herstellung einer holz-flachspanplatte
AT368390B (de) Verfahren zur herstellung einer heterovakzine
AT355594B (de) Verfahren zur reinigung einer verduennten schwefelsaeureloesung
DK444279A (da) Fremgangsmaade til fremstilling af 6-hydroxymethyl-2-(beta-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylsyre
AT354377B (de) Verfahren zur herstellung einer backware
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
AT344676B (de) Verfahren zur herstellung einer perpropionsaeureloesung
ATA653079A (de) Verfahren zur herstellung einer b-beta- -acylaminopenicillansaeure
AT363588B (de) Verfahren zur herstellung einer stabilen sauren sekretinzubereitung
ATA282779A (de) Verfahren zur herstellung einer hetero- klischen verbindung
DD137099A5 (de) Verfahren zur herstellung einer 2-arylpropionsaeure
DD138785A1 (de) Verfahren zur vorbehandlung von metallischen substr&toberflaechen
PT70167A (de) Verfahren zum herstellen einer litze
DD130910A1 (de) Verfahren zur herstellung einer suessware
RO76842A2 (ro) Procedeu de obtinere a acidului 2-clor-4-amino-toluen-5-sulfonic
DD136196A1 (de) Verfahren zur herstellung einer blockwicklung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee